Tazorac Cream

DRUG4 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

AcneAcne VulgarisPsoriasis

Phase 1

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

CompletedNCT02849873

Bausch Health Americas, Inc.Acne

Start: 2016-06-30End: 2017-01-31Updated: 2018-07-19

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

CompletedNCT03058744

Bausch Health Americas, Inc.Psoriasis

Start: 2015-04-30End: 2017-01-31Updated: 2017-06-09

Phase 2

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

CompletedNCT02785159

Bausch Health Americas, Inc.Psoriasis

Start: 2016-02-29End: 2016-12-31Updated: 2020-08-20

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

CompletedNCT02938494

Bausch Health Americas, Inc.Acne Vulgaris

Start: 2015-11-30End: 2016-09-30Updated: 2020-09-23

Related Papers

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials.

2021-08-302 citations